AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers
- First Posted Date
- 2008-08-01
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 32
- Registration Number
- NCT00726427
- Locations
- 🇺🇸
Research Site, Philadelphia, Pennsylvania, United States
To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
Completed
- Conditions
- Hyperlipidemias
- First Posted Date
- 2008-07-31
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 3270
- Registration Number
- NCT00726362
- Locations
- 🇨🇳
Research Site, Yun-Lin, Taiwan
Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin
- First Posted Date
- 2008-07-28
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT00723424
- Locations
- 🇩🇪
Research Site, Berlin, Germany
Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin
Phase 1
Completed
- Conditions
- Healthy VolunteersPharmacokinetics
- Interventions
- Drug: AZD5672Drug: atorvastatin
- First Posted Date
- 2008-07-28
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 12
- Registration Number
- NCT00722956
- Locations
- 🇬🇧
Research Site, London, United Kingdom
An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy
Terminated
- Conditions
- Non-small Cell Lung CancerLung Cancer
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 120
- Registration Number
- NCT00721981
- Locations
- 🇩🇪
Research Site, Trier, Germany
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 7400
- Registration Number
- NCT00722267
- Locations
- 🇬🇧
Research Site, Westbury, United Kingdom
An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Pharmacokinetics
- First Posted Date
- 2008-07-24
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT00721448
- Locations
- 🇨🇳
Research Site, Beijing, China
Assessment of the Effect of Food on ABT-143 Bioavailability
Phase 1
Completed
- Conditions
- Pharmacokinetic Variables
- Interventions
- Drug: ABT-143 ( rosuvastatin calcium and fenofibric acid )Drug: ABT-143 (rosuvastatin calcium and fenofibric acid )
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2012-09-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 115
- Registration Number
- NCT00719693
- Locations
- 🇺🇸
Site Reference ID/Investigator# 9242, Evansville, Indiana, United States
A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 16
- Registration Number
- NCT00720421
- Locations
- 🇳🇱
Centre for Human Drug Research, Leiden, Netherlands
Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.
Completed
- Conditions
- Sprain of Ankle
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2008-09-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 6356
- Registration Number
- NCT00717119
- Locations
- 🇪🇸
Research Site, Madrid, Spain
© Copyright 2025. All Rights Reserved by MedPath